Predictive value of transforming growth factor-β1 gene polymorphism combined with platelet-derived growth factor-BB and C-reactive protein for in-stent restenosis in patients with acute coronary syndrome after PCI
ObjectiveTo investigate the predictive value of transforming growth factor (TGF)-β1 gene polymorphism combined with serum platelet-derived growth factor (PDGF)-BB and C-reactive protein (CRP) levels for coronary artery in-stent restenosis (ISR) in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). MethodA total of 264 ACS patients treated with PCI were enrolled as research subjects and divided into an ISR group or a non-ISR group according to whether they developed ISR during the follow-up period. Univariate analysis and binary logistic regression analysis were used to analyze factors affecting the occurrence of ISR in ACS patients after PCI, and a predictive model for the occurrence of ISR in ACS patients after PCI was constructed. The receiver operating characteristics (ROC) curve was used to analyze each factor′s predictive efficacy. ResultsOf the 264 patients, 70 patients develop ISR (ISR group) and 194 patients did not develop ISR (non-ISR group) during the follow-up period, with an incidence of 26.5%. The proportion of patients whose TGF-β1 gene 509C>T (rs1800469) locus was CC type in the ISR group was higher than that in the non-ISR group (54.3% vs. 30.4%, P<0.05). The serum levels of PDGF-BB and CRP in the ISR group were higher than those in the non-ISR group (all P<0.05). The results of binary logistic regression analysis showed that the CC type at TGF-β1 gene 509C>T (rs1800469) locus and elevated serum levels of PDGF-BB and CRP were independent risk factors for the occurrence of ISR in ACS patients after PCI (all P<0.05). The ROC curve analysis showed that the area under the curve (AUC) of the genotype of TGF-β1 gene 509C>T (rs1800469) locus, serum PDGF-BB level, and serum CRP level in predicting the occurrence of ISR in ACS patients after PCI were 0.866, 0.786, and 0.861, respectively, while their combination′s AUC reached 0.970 (all P<0.05). The final predictive model was P=1/(1+e[-17.015+0.160*PDGF-BB+1.139*CRP+2.517*TGF-β1]). ConclusionTGF-β1 gene polymorphism and serum PDGF-BB and CRP levels are closely related to the occurrence of ISR in ACS patients after PCI, and the combination of the abovementioned three indicators is helpful in predicting the occurrence of ISR after PCI.